Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Q32 Bio (QTTB) EPS (Basic) (2017 - 2025)

Q32 Bio (QTTB) has 9 years of EPS (Basic) data on record, last reported at $4.71 in Q4 2025.

  • For Q4 2025, EPS (Basic) rose 524.32% year-over-year to $4.71; the TTM value through Dec 2025 reached $2.42, up 147.27%, while the annual FY2025 figure was $2.42, 147.27% up from the prior year.
  • EPS (Basic) reached $4.71 in Q4 2025 per QTTB's latest filing, up from -$0.61 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $4.71 in Q4 2025 and bottomed at -$152.28 in Q4 2023.
  • Average EPS (Basic) over 5 years is -$11.69, with a median of -$0.6 recorded in 2022.
  • Peak YoY movement for EPS (Basic): surged 8150.0% in 2022, then crashed 25280.0% in 2023.
  • A 5-year view of EPS (Basic) shows it stood at -$0.59 in 2021, then dropped by 1.69% to -$0.6 in 2022, then plummeted by 25280.0% to -$152.28 in 2023, then surged by 99.27% to -$1.11 in 2024, then skyrocketed by 524.32% to $4.71 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were $4.71 in Q4 2025, -$0.61 in Q3 2025, and -$0.78 in Q2 2025.